Free Trial
OTCMKTS:RGBP

Regen BioPharma (RGBP) Stock Price, News & Analysis

Regen BioPharma logo
$0.06 +0.00 (+4.17%)
As of 05/2/2025 02:10 PM Eastern

About Regen BioPharma Stock (OTCMKTS:RGBP)

Key Stats

Today's Range
$0.05
$0.06
50-Day Range
$0.04
$0.07
52-Week Range
$0.02
$0.60
Volume
2,077 shs
Average Volume
14,089 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is involved in the development of its products, and therapies, including HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. The company was incorporated in 2012 and is based in La Mesa, California.

Receive RGBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter.

RGBP Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Regen BioPharma Inc (RGBP)
See More Headlines

RGBP Stock Analysis - Frequently Asked Questions

Regen BioPharma's stock was trading at $0.0601 at the start of the year. Since then, RGBP stock has increased by 4.0% and is now trading at $0.0625.
View the best growth stocks for 2025 here
.

Regen BioPharma shares split on Thursday, June 20th 2024. The 3-1 split was announced on Thursday, June 20th 2024. The newly minted shares were payable to shareholders after the closing bell on Thursday, June 20th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Shares of RGBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Regen BioPharma investors own include Meta Platforms (META), Trans Global Group (TGGI), Exxe Group (AXXA), DraftKings (DKNG), Enzolytics (ENZC), Alcoa (AA) and Airborne Wireless Network (ABWN).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:RGBP
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:RGBP) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners